StockData
Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc. (EVFM) bonds

EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026Market cap $865.23KP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Evofem Biosciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Evofem Biosciences's 10-Q for the period ended Jun 30, 2026

IssueMaturesAmount issuedCarrying value
Aditxt April NotesApr 8, 2028$2.31M–
Aditxt June NotesJun 26, 2028$1.42M–
Adjuvant Notes
Convertible at $26 a share
–$22.50M$34.01M
Baker Bros Notes
Convertible at $4.58K a share
–$25.00M–
Senior Subordinated Notes–$14.72M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?